Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients is a paper indexed in PICO Portal from OpenAlex.
How many citations does Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients have?
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients has 161 citations in the OpenAlex counts PICO Portal stores.
When was Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients published?
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients has 2002 year in the PICO Portal index.
What is the open-access status of Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients?
Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients has bronze oa status in the PICO Portal index.
What is the DOI of Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients?
The DOI for Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients is on the source record.
What is the PMID of Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients?
The PMID for Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients is on the source record.
What is the OpenAlex record for Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients?
The OpenAlex for Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients is on the source record.